Since hVEGFA modRNA harnesses great therapeutic potential and drug company including AstraZeneca has already filed clinical trial application with an attempt to use VEGFA modRNA in treating cardiovascular diseases, our results might foster future development of VEGFA modRNA for treatment of other diseases including diabetes. The gene discussed is VEGFA; the disease is cardiovascular disorder.